28240655|t|Impending Atypical Femoral Fracture in Patients With Medullary Thyroid Cancer With Skeletal Metastasis Treated With Long-term Bisphosphonate and Denosumab
28240655|a|Atypical femoral fractures (AFFs) occur in osteoporosis patients receiving long-term bisphosphonate. Atypical femoral fractures also occur in cancer patients receiving long-term bisphosphonate or denosumab, but the prevalence is low. We describe a 53- year -old woman with a history of medullary thyroid cancer and skull metastasis who was prescribed bisphosphonate for 6 years and denosumab for 1.5 years, consecutively. Bone scintigraphy performed because of spontaneous groin pain showed uptake in the lateral aspect of the left femur, which was confirmed as impending AFF. In oncological patients receiving long-term bisphosphonate or denosumab, AFF should be included as a differential diagnosis with focal femoral findings.
28240655	0	9	Impending	T079	C0332190
28240655	10	35	Atypical Femoral Fracture	T046	C4268744
28240655	39	47	Patients	T101	C0030705
28240655	53	77	Medullary Thyroid Cancer	T191	C0238462
28240655	83	91	Skeletal	T082	C0521324
28240655	92	102	Metastasis	T046	C4255448
28240655	103	110	Treated	T169	C1522326
28240655	116	125	Long-term	T079	C0443252
28240655	126	140	Bisphosphonate	T121	C2267018
28240655	145	154	Denosumab	T116,T121,T129	C1690432
28240655	155	181	Atypical femoral fractures	T046	C4268744
28240655	183	187	AFFs	T046	C4268744
28240655	198	210	osteoporosis	T047	C0029456
28240655	211	219	patients	T101	C0030705
28240655	230	239	long-term	T079	C0443252
28240655	240	254	bisphosphonate	T121	C2267018
28240655	256	282	Atypical femoral fractures	T046	C4268744
28240655	297	312	cancer patients	T101	C1516213
28240655	323	332	long-term	T079	C0443252
28240655	333	347	bisphosphonate	T121	C2267018
28240655	351	360	denosumab	T116,T121,T129	C1690432
28240655	370	380	prevalence	T081	C0033105
28240655	384	387	low	T080	C0205251
28240655	407	411	year	T079	C0439234
28240655	417	422	woman	T098	C0043210
28240655	441	465	medullary thyroid cancer	T191	C0238462
28240655	470	486	skull metastasis	T191	C2026272
28240655	495	505	prescribed	T058	C0278329
28240655	506	520	bisphosphonate	T121	C2267018
28240655	527	532	years	T079	C0439234
28240655	537	546	denosumab	T116,T121,T129	C1690432
28240655	555	560	years	T079	C0439234
28240655	562	575	consecutively	T080	C1707491
28240655	577	594	Bone scintigraphy	T060	C3889015
28240655	595	604	performed	T169	C0884358
28240655	616	627	spontaneous	T169	C0205359
28240655	628	638	groin pain	T184	C0239783
28240655	646	652	uptake	T039	C0243144
28240655	682	692	left femur	T023	C0817320
28240655	717	726	impending	T079	C0332190
28240655	727	730	AFF	T046	C4268744
28240655	735	746	oncological	T191	C0027651
28240655	747	755	patients	T101	C0030705
28240655	766	775	long-term	T079	C0443252
28240655	776	790	bisphosphonate	T121	C2267018
28240655	794	803	denosumab	T116,T121,T129	C1690432
28240655	805	808	AFF	T046	C4268744
28240655	833	855	differential diagnosis	T060	C0011906
28240655	861	866	focal	T082	C0205234
28240655	867	874	femoral	T023	C0015811
28240655	875	883	findings	T033	C0243095